BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 18096251)

  • 1. Treatment of Crimean-Congo hemorrhagic fever.
    Ergonul O
    Antiviral Res; 2008 Apr; 78(1):125-31. PubMed ID: 18096251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crimean-Congo hemorrhagic fever.
    Whitehouse CA
    Antiviral Res; 2004 Dec; 64(3):145-60. PubMed ID: 15550268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in molecular biology of Crimean-Congo hemorrhagic fever.
    Morikawa S; Saijo M; Kurane I
    Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):375-89. PubMed ID: 17692916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.
    Elaldi N; Bodur H; Ascioglu S; Celikbas A; Ozkurt Z; Vahaboglu H; Leblebicioglu H; Yilmaz N; Engin A; Sencan M; Aydin K; Dokmetas I; Cevik MA; Dokuzoguz B; Tasyaran MA; Ozturk R; Bakir M; Uzun R
    J Infect; 2009 Mar; 58(3):238-44. PubMed ID: 19246100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Crimean-Congo hemorrhagic fever: basics for general practitioners].
    Flusin O; Iseni F; Rodrigues R; Paranhos-Baccalà G; Crance JM; Marianneau P; Bouloy M; Peyrefitte CN
    Med Trop (Mars); 2010 Dec; 70(5-6):429-38. PubMed ID: 21520641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.
    Mardani M; Jahromi MK; Naieni KH; Zeinali M
    Clin Infect Dis; 2003 Jun; 36(12):1613-8. PubMed ID: 12802764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crimean-Congo hemorrhagic fever.
    Vorou R; Pierroutsakos IN; Maltezou HC
    Curr Opin Infect Dis; 2007 Oct; 20(5):495-500. PubMed ID: 17762783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of the M RNA segment of Crimean-Congo hemorrhagic fever virus strains in Turkey.
    Ozdarendeli A; Aydin K; Tonbak S; Aktas M; Altay K; Koksal I; Bolat Y; Dumanli N; Kalkan A
    Arch Virol; 2008; 153(1):37-44. PubMed ID: 17955162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment of Crimean-Congo hemorrhagic fever in children.
    Mardani M; Rahnavardi M; Sharifi-Mood B
    Expert Rev Anti Infect Ther; 2010 Aug; 8(8):911-8. PubMed ID: 20695747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey.
    Ertugrul B; Uyar Y; Yavas K; Turan C; Oncu S; Saylak O; Carhan A; Ozturk B; Erol N; Sakarya S
    Int J Infect Dis; 2009 Nov; 13(6):e431-6. PubMed ID: 19409826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.
    Koksal I; Yilmaz G; Aksoy F; Aydin H; Yavuz I; Iskender S; Akcay K; Erensoy S; Caylan R; Aydin K
    J Clin Virol; 2010 Jan; 47(1):65-8. PubMed ID: 19962342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Crimean-Congo Hemorrhagic Fever].
    Güneş T
    Mikrobiyol Bul; 2006 Jul; 40(3):279-87. PubMed ID: 17001860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy.
    Ergönül O; Celikbaş A; Dokuzoguz B; Eren S; Baykam N; Esener H
    Clin Infect Dis; 2004 Jul; 39(2):284-7. PubMed ID: 15307042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange and ribavirin.
    Kurnaz F; Metan G; Coskun R; Kaynar L; Eser B; Doganay M
    Trop Doct; 2011 Jul; 41(3):181-2. PubMed ID: 21565949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey].
    Uyar Y; Carhan A; Albayrak N; Altaş AB
    Mikrobiyol Bul; 2010 Jan; 44(1):57-64. PubMed ID: 20455399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study.
    Izadi S; Salehi M
    Jpn J Infect Dis; 2009 Jan; 62(1):11-5. PubMed ID: 19168952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy.
    Ozkurt Z; Kiki I; Erol S; Erdem F; Yilmaz N; Parlak M; Gundogdu M; Tasyaran MA
    J Infect; 2006 Mar; 52(3):207-15. PubMed ID: 15953646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies.
    Keshtkar-Jahromi M; Kuhn JH; Christova I; Bradfute SB; Jahrling PB; Bavari S
    Antiviral Res; 2011 May; 90(2):85-92. PubMed ID: 21362441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crimean Congo hemorrhagic fever: requires vigilance and not panic.
    Bajpai S; Nadkar MY
    J Assoc Physicians India; 2011 Mar; 59():164-7. PubMed ID: 21751625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards an understanding of the migration of Crimean-Congo hemorrhagic fever virus.
    Mild M; Simon M; Albert J; Mirazimi A
    J Gen Virol; 2010 Jan; 91(Pt 1):199-207. PubMed ID: 19812264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.